Dr. Laura M. Dember, MD
Claim this profileUniversity of Pennsylvania
Studies Contrast-induced Nephropathy
Studies Chronic Kidney Disease
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Laura M. Dember, MD is currently running
Symptom Monitoring
for Kidney Failure
The SMaRRT-HD trial is a cluster randomized trial of symptom monitoring with supported clinician follow-up using the SMaRRT-HD electronic patient reported outcome measure (ePROM) system versus Usual Care. Approximately 2400 patients at 30 geographically and racially diverse US hemodialysis clinics will be enrolled. The primary trial hypothesis is that regular symptom patient reported outcome measure (PROM) administration with supported clinician follow-up in dialysis care will reduce suffering and improve outcomes by prompting treatment of unrecognized symptoms, and enhancing patient-care team communication. Clinics randomized to the SMaRRT-HD group will adopt the use of SMaRRT-HD for 12 months. SMaRRT-HD is a symptom monitoring system that includes 1) tablet-based symptom reporting using a PROM and 2) supported clinician follow-up consisting of symptom alerts, guidances for symptom management, and symptom tracking reports that are shared with patients. Dialysis clinics randomized to Usual Care will not adopt SMaRRT-HD or any other trial-driven procedures. Usual Care clinics will monitor symptoms through clinical care interactions with participants and by administering a Health Related Quality of Life survey that includes questions about symptoms.
Recruiting1 award N/A3 criteria
Educational Strategies
for Advanced Kidney Disease
The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 approaches: 1) "Education", in which participants will be given a video and brochure that provide information about the types of vascular access and what can be expected before and after the vascular access is placed, 2) "Education-Plus", in which participants will be given the video and brochure and will also have sessions by telehealth with a motivational interviewing coach to provide additional support around vascular access placement, and 3) "Usual Care", in which participants will have the usual education provided by their kidney doctor and clinic staff just as if they were not in the study. Participants in all 3 groups will be asked to complete questionnaires by telephone and may be invited to be interviewed about their experience with the study intervention at the end of the study. Study participation will last for about 12 months, with most of the study activities taking place during the first 3 months.
Recruiting1 award N/A4 criteria
More about Laura M. Dember, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Laura M. Dember, MD has experience with
- Usual Care
- Educational Materials
- Motivational Interviewing
- Symptom Monitoring On Renal Replacement Therapy - Hemodialysis (SMaRRT-HD)
Breakdown of trials Laura M. Dember, MD has run
Contrast-induced Nephropathy
Chronic Kidney Disease
Hemodialysis Vascular Access
Kidney Disease
Kidney Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Laura M. Dember, MD specialize in?
Laura M. Dember, MD focuses on Contrast-induced Nephropathy and Chronic Kidney Disease. In particular, much of their work with Contrast-induced Nephropathy has involved treating patients, or patients who are undergoing treatment.
Is Laura M. Dember, MD currently recruiting for clinical trials?
Yes, Laura M. Dember, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Laura M. Dember, MD has studied deeply?
Yes, Laura M. Dember, MD has studied treatments such as Usual Care, Educational Materials, Motivational Interviewing.
What is the best way to schedule an appointment with Laura M. Dember, MD?
Apply for one of the trials that Laura M. Dember, MD is conducting.
What is the office address of Laura M. Dember, MD?
The office of Laura M. Dember, MD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19106 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.